Free Trial

Avantor, Inc. (NYSE:AVTR) Stock Has Consensus Target Price of $12.47 According to Brokerages

Avantor logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts have a consensus “Hold” rating on Avantor, with 15 hold, two buy, and one sell recommendation. The average 12-month price target is $12.47, below the stock’s reported opening price of $15.46.
  • Institutional investors own 95.08% of Avantor’s shares, with several firms recently increasing their positions.
  • Avantor exceeded quarterly expectations, reporting $0.21 in adjusted EPS versus a $0.19 estimate and revenue of $1.69 billion versus the $1.61 billion consensus forecast. Management guided to fiscal 2026 EPS of $0.80–$0.83.
  • MarketBeat previews top five stocks to own in November.

Shares of Avantor, Inc. (NYSE:AVTR - Get Free Report) have earned a consensus recommendation of "Hold" from the eighteen ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $12.47.

Several equities analysts have weighed in on AVTR shares. Royal Bank Of Canada lifted their price objective on Avantor from $9.00 to $14.00 and gave the company a "sector perform" rating in a report on Thursday, July 30th. Wolfe Research raised shares of Avantor from a "strong sell" rating to a "hold" rating in a research report on Thursday, July 30th. Evercore set a $10.50 target price on shares of Avantor in a report on Monday, July 6th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $13.00 price target on shares of Avantor in a report on Thursday, July 30th. Finally, Stifel Nicolaus lifted their price objective on shares of Avantor from $8.00 to $15.00 and gave the company a "hold" rating in a research note on Thursday, July 30th.

Check Out Our Latest Stock Report on AVTR

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Parallel Advisors LLC grew its holdings in Avantor by 21.4% during the first quarter. Parallel Advisors LLC now owns 8,452 shares of the company's stock worth $66,000 after buying an additional 1,491 shares in the last quarter. Kera Capital Partners Inc. boosted its holdings in Avantor by 8.6% during the 4th quarter. Kera Capital Partners Inc. now owns 24,992 shares of the company's stock worth $273,000 after acquiring an additional 1,971 shares during the last quarter. Pictet Asset Management Holding SA boosted its holdings in Avantor by 2.2% during the 1st quarter. Pictet Asset Management Holding SA now owns 106,835 shares of the company's stock worth $838,000 after acquiring an additional 2,274 shares during the last quarter. Hsbc Holdings PLC grew its stake in shares of Avantor by 8.0% in the 2nd quarter. Hsbc Holdings PLC now owns 33,534 shares of the company's stock worth $332,000 after acquiring an additional 2,497 shares in the last quarter. Finally, HighTower Advisors LLC raised its holdings in shares of Avantor by 3.4% in the second quarter. HighTower Advisors LLC now owns 85,072 shares of the company's stock valued at $842,000 after purchasing an additional 2,787 shares during the last quarter. Institutional investors own 95.08% of the company's stock.

Avantor Price Performance

Shares of Avantor stock opened at $15.46 on Wednesday. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $10.45 billion, a price-to-earnings ratio of -18.40, a price-to-earnings-growth ratio of 11.93 and a beta of 0.94. Avantor has a twelve month low of $7.26 and a twelve month high of $16.38. The company has a 50-day simple moving average of $14.58 and a two-hundred day simple moving average of $10.97.

Avantor (NYSE:AVTR - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. The company had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.61 billion. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The business's revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm earned $0.24 earnings per share. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Analysts forecast that Avantor will post 0.81 EPS for the current year.

Avantor Company Profile

(Get Free Report)

Avantor, Inc is a global provider of products, services and solutions used in the life sciences and advanced technology industries. The company supplies materials and equipment that support research, drug discovery and development, biopharmaceutical manufacturing, clinical and diagnostic activities, and other laboratory applications.

Its offerings include laboratory chemicals and reagents, consumables, single-use manufacturing technologies, bioprocessing products, equipment, and related services.

Recommended Stories

Analyst Recommendations for Avantor (NYSE:AVTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines